608 results match your criteria: "Institute for Memory Impairments and Neurological Disorders[Affiliation]"

The loss of olfactory stimulation correlates well with at least 68 widely differing neurological disorders, including depression, and we raise the possibility that this relationship may be causal. That is, it seems possible that olfactory loss makes the brain vulnerable to expressing the symptoms of these neurological disorders, while daily olfactory enrichment may decrease the risk of expressing these symptoms. This situation resembles the cognitive reserve that is thought to protect people with Alzheimer's neuropathology from expressing the functional deficit in memory through the cumulative effect of intellectual stimulation.

View Article and Find Full Text PDF

Background: Clinical trials now test promising therapies in the preclinical stages of Alzheimer's disease (AD). Participant willingness to enroll in different types of preclinical AD trials is understudied and whether the FDA approval of aducanumab affected these attitudes is unknown.

Objective: To evaluate preferences toward three preclinical AD trial scenarios and whether the FDA approval of aducanumab changed willingness to participate among potential trial participants.

View Article and Find Full Text PDF

Blood pressure variability and plasma Alzheimer's disease biomarkers in older adults.

Sci Rep

October 2022

Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, 4201 Social and Behavioral Sciences Gateway, Irvine, CA, 92697-7085, USA.

Blood pressure variability is an emerging risk factor for Alzheimer's disease in older adults, independent of average blood pressure levels. Growing evidence suggests increased blood pressure variability is linked to Alzheimer's disease pathophysiology indexed by cerebrospinal fluid and positron emission tomography markers, but relationships with plasma Alzheimer's disease markers have not been investigated. In this cross-sectional study of 54 community-dwelling older adults (aged 55-88, mean age 69.

View Article and Find Full Text PDF

Pathological forms of Tau protein are directly associated with neurodegeneration and correlate with Alzheimer's Disease (AD) symptoms, progression, and severity. Previously, using various mouse models of Tauopathies and AD, we have demonstrated the immunogenicity and efficacy of the MultiTEP-based adjuvanted vaccine targeting the phosphatase activating domain (PAD) of Tau, AV-1980R/A. Here, we analyzed its immunogenicity in non-human primates (NHP), the closest phylogenic relatives to humans with a similar immune system, to initiate the transition of this vaccine into clinical trials.

View Article and Find Full Text PDF

Heavy alcohol consumption is a known risk factor for various forms of dementia and the development of Alzheimer's disease (AD). In this work, we investigated how intragastric alcohol feeding may alter the liver-to-brain axis to induce and/or promote AD pathology. Four weeks of intragastric alcohol feeding to mice, which causes significant fatty liver (steatosis) and liver injury, caused no changes in AD pathology markers in the brain [amyloid precursor protein (APP), presenilin], except for a decrease in microglial cell number in the cortex of the brain.

View Article and Find Full Text PDF

Background: When studying drug effects using observational data, time-related biases may exist and result in spurious associations. Numerous observational studies have investigated metformin and dementia risk, but have reported inconsistent findings, some of which might be caused by unaddressed time-related biases. Immortal time bias biases the results toward a "protective" effect, whereas time-lag and time-window biases can lead to either a "detrimental" or "protective" effect.

View Article and Find Full Text PDF

Preclinical Alzheimer Disease and the Electronic Health Record: Balancing Confidentiality and Care.

Neurology

November 2022

From the Department of Neurology (S.A.G.), Center for Brain/Mind Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Department of Neurology (J.H.), the University of Michigan, Ann Arbor, MI; Institute for Memory Impairments and Neurological Disorders (J.G., Shirley Sirivong), University of California Irvine; Department of Neurology (J.G.-R.), Mayo Clinic, Rochester, MN; Department of Neurology (G.A.J.), Sanders-Brown Center on Aging, University of Kentucky, Lexington; Memory and Aging Program (W.M.), Butler Hospital; Division of Geriatric Psychiatry and Neuropsychiatry (M.N.), Department of Psychiatry, Johns Hopkins University School of Medicine; Brain Health and Memory Center (Susie Sami), University Hospitals, Cleveland Medical Center; Alzheimer's Therapeutic Research Institute (S.W.), University of Southern California; and University of Pennsylvania (J.K.), Departments of Medicine, Medical Ethics and Health Policy, and Neurology, Penn Memory Center.

Because information technologies are increasingly used to improve clinical research and care, personal health information (PHI) has wider dissemination than ever before. The 21st Century Cures Act in the United States now requires patient access to many components of the electronic health record (EHR). Although these changes promise to enhance communication and information sharing, they also bring higher risks of unwanted disclosure, both within and outside of health systems.

View Article and Find Full Text PDF

The ability to learn associations between events is critical for everyday functioning (e.g., decision making, social interactions) and has been attributed to structural differences in white matter tracts connecting cortical regions to the hippocampus (e.

View Article and Find Full Text PDF

Older Adults With Higher Blood Pressure Variability Exhibit Cerebrovascular Reactivity Deficits.

Am J Hypertens

January 2023

Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, Irvine, CA 92697, USA.

Background: Elevated blood pressure (BP) variability is predictive of increased risk for stroke, cerebrovascular disease, and other vascular brain injuries, independent of traditionally studied average BP levels. However, no studies to date have evaluated whether BP variability is related to diminished cerebrovascular reactivity, which may represent an early marker of cerebrovascular dysfunction presaging vascular brain injury.

Methods: The present study investigated BP variability and cerebrovascular reactivity in a sample of 41 community-dwelling older adults (mean age 69.

View Article and Find Full Text PDF

Truncation mutations in MYRF underlie primary angle closure glaucoma.

Hum Genet

January 2023

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, 54 Xianlie Road, Guangzhou, 510060, China.

Mutations in myelin regulatory factor (MYRF), a gene mapped to 11q12-q13.3, are responsible for autosomal dominant high hyperopia and seem to be associated with angle closure glaucoma, which is one of the leading causes of irreversible blindness worldwide. Whether there is a causal link from the MYRF mutations to the pathogenesis of primary angle-closure glaucoma (PACG) remains unclear at this time.

View Article and Find Full Text PDF

Economic hardships of Korean American family caregivers of persons with dementia: a mixed-methods study.

Aging Ment Health

September 2022

UC Irvine Institute for Memory Impairments and Neurological Disorders (UCI MIND), University of California Irvine, Irvine, CA, USA.

This study examined the relationships between economic hardships (i.e. perceived financial hardship and job interference) and caregiver burden among Korean American family caregivers of persons with dementia and explored their lived experience caring for their loved ones.

View Article and Find Full Text PDF

Exploring the role of sex differences in Alzheimer's disease pathogenesis in Down syndrome.

Front Neurosci

August 2022

Department of Pathology and Laboratory Medicine, University of California, Irvine, Irvine, CA, United States.

Article Synopsis
  • Women are more affected by Alzheimer's disease, but the specific impact on women with Down syndrome (DS) and how sex differences influence Alzheimer's development remains under-researched.
  • The 21st chromosome, which is duplicated in DS, contains the amyloid precursor protein (APP) gene linked to Alzheimer's, leading to a high accumulation of amyloid-beta and neurofibrillary tangles in affected individuals around their early to mid-40s.
  • Research indicates that women with DS face earlier menopause and a drop in estrogen compared to their counterparts without DS, suggesting hormonal factors may influence Alzheimer's disease progression in this population.
View Article and Find Full Text PDF

Tau aggregation in neurofibrillary tangles (NFTs) is closely associated with neurodegeneration and cognitive decline in Alzheimer's disease (AD). However, the molecular signatures that distinguish between aggregation-prone and aggregation-resistant cell states are unknown. We developed methods for the high-throughput isolation and transcriptome profiling of single somas with NFTs from the human AD brain, quantified the susceptibility of 20 neocortical subtypes for NFT formation and death, and identified both shared and cell-type-specific signatures.

View Article and Find Full Text PDF

Platelet-derived growth factor-BB and white matter hyperintensity burden in carriers.

Cereb Circ Cogn Behav

March 2022

Department of Psychological Science, University of California Irvine, Irvine, CA, United States.

Background: The apolipoprotein-e4 () gene increases risk for developing late-onset Alzheimer's disease (AD) and has been linked to increased microvascular dysfunction, including pericyte degeneration and blood-brain barrier breakdown. Platelet-derived growth factor-BB (PDGF-BB) is a glycoprotein involved in blood-brain barrier and pericyte maintenance. Increased PDGF-BB levels have been reported in white matter in AD brain tissue.

View Article and Find Full Text PDF

Medial temporal lobe (MTL) atrophy is a core feature of age-related cognitive decline and Alzheimer's disease (AD). While regional volumes and thickness are often used as a proxy for neurodegeneration, they lack the sensitivity to serve as an accurate diagnostic test and indicate advanced neurodegeneration. Here, we used a submillimeter resolution diffusion weighted MRI sequence (ZOOMit) to quantify microstructural properties of hippocampal subfields in older adults (63-98 years old) using tensor derived measures: fractional anisotropy (FA) and mean diffusivity (MD).

View Article and Find Full Text PDF

Histone modifications are key contributors to the cognitive decline that occurs in aging and Alzheimer's disease. Our lab has previously shown that elevated H3K9me3 in aged mice is correlated with synaptic loss, cognitive impairment and a reduction in brain derived neurotrophic factor (BDNF). However, the mechanism of H3K9me3 regulation remains poorly understood.

View Article and Find Full Text PDF

Temporal endurance of exercise-induced benefits on hippocampus-dependent memory and synaptic plasticity in female mice.

Neurobiol Learn Mem

October 2022

Department of Neurobiology and Behavior, School of Biological Sciences University of California, Irvine 92697-2695, United States; Center for the Neurobiology of Learning and Memory (CNLM), University of California, Irvine 92697-2695, United States; Institute for Memory Impairments and Neurological Disorders (UCI MIND), University of California, Irvine 92697-2695, United States. Electronic address:

Exercise facilitates hippocampal neurogenesis and neuroplasticity that in turn, promotes cognitive function. Our previous studies have demonstrated that in male mice, voluntary exercise enables hippocampus-dependent learning in conditions that are normally subthreshold for long-term memory formation in sedentary animals. Such cognitive enhancement can be maintained long after exercise has ceased and can be re-engaged by a subsequent subthreshold exercise session, suggesting exercise-induced benefits are temporally dynamic.

View Article and Find Full Text PDF

Objectives: Alzheimer disease (AD) and related dementias clinical research is associated with significant participant burden. The Perceived Research Burden Assessment (PeRBA) measures participants' perceptions of logistical, psychological, and physical burdens. The purpose of this study was to assess PeRBA's psychometric properties, perceptual sources, and behavioral consequences with participants in a multisite study of participant retention in longitudinal cohort studies of Alzheimer disease and related dementias.

View Article and Find Full Text PDF

Blood pressure variability is an emerging risk factor for stroke, cognitive impairment, and dementia, possibly through links with cerebral hypoperfusion. Recent evidence suggests visit-to-visit (e.g.

View Article and Find Full Text PDF

Protocol for single-nucleus ATAC sequencing and bioinformatic analysis in frozen human brain tissue.

STAR Protoc

September 2022

Department of Neurobiology and Behavior, University of California, Irvine, Irvine, CA, USA; Mathematical, Computational and Systems Biology Program, UC Irvine, Irvine, CA, USA; Institute for Memory Impairments and Neurological Disorders (MIND), Irvine, CA, USA. Electronic address:

Single-nucleus ATAC sequencing (snATAC-seq) employs a hyperactive Tn5 transposase to gain precise information about the cis-regulatory elements in specific cell types. However, the standard protocol of snATAC-seq is not optimized for all tissues, including the brain. Here, we present a modified protocol for single-nuclei isolation from postmortem frozen human brain tissue, followed by snATAC-seq library preparation and sequencing.

View Article and Find Full Text PDF

Cholesterol and matrisome pathways dysregulated in astrocytes and microglia.

Cell

June 2022

Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Nash Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Ronald M. Loeb Center for Alzheimer's Disease, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Electronic address:

The impact of apolipoprotein E ε4 (APOE4), the strongest genetic risk factor for Alzheimer's disease (AD), on human brain cellular function remains unclear. Here, we investigated the effects of APOE4 on brain cell types derived from population and isogenic human induced pluripotent stem cells, post-mortem brain, and APOE targeted replacement mice. Population and isogenic models demonstrate that APOE4 local haplotype, rather than a single risk allele, contributes to risk.

View Article and Find Full Text PDF

Absence of microglia promotes diverse pathologies and early lethality in Alzheimer's disease mice.

Cell Rep

June 2022

Department of Neurobiology & Behavior, UC Irvine, Irvine, CA 92697, USA; Sue and Bill Gross Stem Cell Research Center, UC Irvine, Irvine, CA 92697, USA; Institute for Memory Impairments and Neurological Disorders, UC Irvine, Irvine, CA 92697, USA. Electronic address:

Article Synopsis
  • - Microglia play a critical role in Alzheimer's disease, but their specific influence on disease progression and lifespan is not well understood.
  • - Researchers created a mouse model lacking microglia, leading to an increase in cerebral amyloid angiopathy, brain calcification, hemorrhages, and premature death; injecting healthy microglia reversed these effects.
  • - Analysis of human Alzheimer's tissue revealed that microglia can engulf calcium crystals, a process hindered by the loss of the TREM2 gene, which is linked to increased Alzheimer's risk.
View Article and Find Full Text PDF

Parkinson's disease (PD) and dementia with Lewy bodies (DLB) are characterized by the aberrant accumulation of intracytoplasmic misfolded and aggregated α-synuclein (α-Syn), resulting in neurodegeneration associated with inflammation. The propagation of α-Syn aggregates from cell to cell is implicated in the spreading of pathological α-Syn in the brain and disease progression. We and others demonstrated that antibodies generated after active and passive vaccinations could inhibit the propagation of pathological α-Syn in the extracellular space and prevent/inhibit disease/s in the relevant animal models.

View Article and Find Full Text PDF